Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Neurol (Paris) ; 149(10): 547-53, 1993.
Artigo em Francês | MEDLINE | ID: mdl-8023069

RESUMO

We observed 40 patients aged from 15 to 40 years who suffered either a transient ischemic attack or an arterial ischemic stroke. All patients were clinically and physically examined, i.e. chest-X rays, electrocardiograms, biological tests and C.T. scan or magnetic resonance imaging that confirmed the diagnosis of ischemic cerebral infarction. Most patients underwent echocardiography and angiography. The time span between the onset of the ischemic event and angiography was recorded. A few of them had CSF analysis and determinations of antithrombin III, protein C and protein S. The etiology was confirmed in 15 patients (5 cardioembolic diseases, 7 vasculopathies, 3 coagulopathies). Twenty three had well-known vascular risk factors, but also an increase in serum fibrinogen concentration, which might have been associated with specific predisposing factors: oral contraceptives, patent foramen ovale, migraine, craniocervical trauma, acute alcohol intoxication and infectious diseases. No cause was found in 2 patients. We suggest a practical approach and highlight the value of angiography when performed early in the course of the illness to enhance the percentage of positive diagnosis. About 45 p. 100 of the patients followed-up (mean duration: 3 years) were unable to resume normal professional activity.


Assuntos
Isquemia Encefálica/etiologia , Infarto Cerebral/etiologia , Adolescente , Adulto , Isquemia Encefálica/diagnóstico , Doenças Cardiovasculares/complicações , Angiografia Cerebral , Infarto Cerebral/diagnóstico , Feminino , Seguimentos , Humanos , Masculino , Estudos Retrospectivos , Fatores de Risco , Fumar/efeitos adversos
2.
Rev Neurol (Paris) ; 148(6-7): 493-5, 1992.
Artigo em Francês | MEDLINE | ID: mdl-1448669

RESUMO

We report the results of a combined of chemotherapy with CDDP and 5 FU repeated every 3 weeks in sixteen men (age range 31-73 years) with brain metastases. CT was performed after 2, 4 and 6 cycles to assess efficiency. Response was considered complete when no lesion was found on the CT scan and partial when the lesion shrunk to least half its the total volume. After two cycles, the response rate was 8/16 (50%). Treatment toxicity was mild with only one case of severe but reversible myelotoxicity (grade III). CDDP and 5 FU combined chemotherapy can be a useful treatment for brain metastasis of lung carcinoma.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Encefálicas/tratamento farmacológico , Carcinoma Broncogênico/patologia , Neoplasias Pulmonares/patologia , Adulto , Idoso , Neoplasias Encefálicas/diagnóstico por imagem , Cisplatino/administração & dosagem , Fluoruracila/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
3.
Bull Cancer ; 78(9): 831-7, 1991.
Artigo em Francês | MEDLINE | ID: mdl-1751834

RESUMO

Chemotherapy is not a common treatment for cerebral metastases. The authors report results of combination chemotherapy with cisplatin (CDDP) and fluorouracil (5-FU). Sixteen men (age range 31-73 years) with brain metastases were treated with CDDP 20 mg/m2/day in continuous infusion for 5 days (d 1-5) and 5-FU 1 g/m2/day in continuous infusion for 4 days (d 1-4), and the treatment schedule repeated every 3 weeks. A brain computerized tomography after 2, 4 and 6 cycles was performed to assess efficacy. It was considered that complete response was achieved if no lesion was found on the CT scan, and partial response if at least half of the total volume had decreased. After 2 cycles, the response rate was therefore 8/16 (50%). Treatment toxicity was very mild with only 1 case of severe but reversible myelotoxicity (grade III). It is concluded that chemotherapy combination with CDDP and 5-FU is a useful treatment for brain metastasis of lung carcinoma.


Assuntos
Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/secundário , Cisplatino/uso terapêutico , Fluoruracila/uso terapêutico , Neoplasias Pulmonares/patologia , Adulto , Idoso , Neoplasias Encefálicas/diagnóstico por imagem , Cisplatino/administração & dosagem , Quimioterapia Combinada , Ecoencefalografia , Fluoruracila/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
4.
Neurophysiol Clin ; 20(4): 253-8, 1990 Oct.
Artigo em Francês | MEDLINE | ID: mdl-2290409

RESUMO

We present a case of lesion of the deep branch of ulnar nerve at the wrist caused by fracture of the hook of the hamate. According to Wu's classification (1985) based on clinical and electromyographic findings and the clinicoanatomic correlations, our case corresponds to type IV of this classification with a pure motor ulnar neuropathy with sparing of hypothenar muscles. Improvement was observed after surgery.


Assuntos
Fraturas da Ulna/complicações , Nervo Ulnar/lesões , Traumatismos do Punho/diagnóstico por imagem , Adulto , Eletromiografia , Humanos , Masculino , Neurônios Motores/fisiologia , Radiografia , Fraturas da Ulna/diagnóstico por imagem , Fraturas da Ulna/fisiopatologia , Nervo Ulnar/diagnóstico por imagem , Nervo Ulnar/fisiopatologia , Traumatismos do Punho/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA